4//SEC Filing
ROWLAND LLOYD A 4
Accession 0001140361-23-012616
CIK 0001501989other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:43 PM ET
Size
4.5 KB
Accession
0001140361-23-012616
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Sale
Common Stock
2023-03-16$1.98/sh−2,037$4,031→ 71,095 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 41,875 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001236395
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 6:43 PM ET
- Size
- 4.5 KB